Belinda Avalos, MD

Andrew Moreno

DocwireNews

Belinda Avalos, MD, is 2025 President of the American Society of Hematology (ASH), as well as Professor of Medicine and Senior Advisor to the President at Atrium Health Levine Cancer Institute in Charlotte, North Carolina. In an interview with Heme Today, Dr. Avalos spoke about the ASH Minority Recruitment Initiative (MRI), recently renamed the Hematology Inclusion Pathway.
MRI was launched in 2003 to advance underrepresented societal groups within the hematology practitioner ranks, clinical research, and academia. During the interview, Dr. Avalos noted that the program was also begun to help address unique therapeutic issues faced by specific patient populations.
“We know that individuals with sickle cell disease have been long neglected, and we also know that there are Hispanic patients who have a higher incidence of a certain kind of leukemia, and getting them into a remission and possibly a transplant, can be difficult,” Dr. Avalos elaborated.
Dr. Avalos spoke on a study she conducted with colleagues, published in Blood Advances, to evaluate the performance of MRI. She described how success was defined for the program, measuring the effect from the Initiative on physician attrition rates as compared with national trends, awards earned, and academic appointments received.
“Our program has shown that it is successful in terms of recruiting individuals into the field. Our early results suggest that we are retaining individuals within the field itself, which is very important,” Dr. Avalos summarized.
In closing, she explained the importance of diversity advancement programs for clinical practice in hematology today. She highlighted ASH’s continued efforts to enhance and foster cooperation among such programs nationally and internationally.
“The American Society of Hematology is a convener of organizations and people, and so we are always looking for people to collaborate with,” said Dr. Avalos.

Rob Dillard

Learn More About Hantavirus, the Infection that Killed Gene Hackman’s Wife

Infectious Disease

Dr. Amin Mirhadi

Dr. Mirhadi on Optimizing Radiation Therapy in Head and Neck Cancer

Head and Neck Cancer

Mithu Maheswaranathan, MD

Analyzing the Efficacy, Safety of Obinutuzumab in Lupus Nephritis

Lupus

Latest News

Belinda Avalos, MD, Describes ASH’s Efforts to Promote, Hone Diversity Within Hematology

Hematology

ASH's efforts pertain to professional recruitment as well as to address unique medical issues in patient populations.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe